guaifenesin has been researched along with Infections, Coronavirus in 7 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 7 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y | 1 |
Wang, X | 1 |
Zhang, E | 1 |
Liu, R | 1 |
Yang, C | 1 |
Duan, Y | 1 |
Jiang, Y | 1 |
Yang, Q | 1 |
Esam, Z | 2 |
Matson, MJ | 1 |
Yinda, CK | 1 |
Seifert, SN | 1 |
Bushmaker, T | 1 |
Fischer, RJ | 1 |
van Doremalen, N | 1 |
Lloyd-Smith, JO | 1 |
Munster, VJ | 1 |
Khashkhosha, HK | 1 |
Elhadi, M | 1 |
Pujadas, E | 1 |
Chaudhry, F | 1 |
McBride, R | 1 |
Richter, F | 1 |
Zhao, S | 1 |
Wajnberg, A | 1 |
Nadkarni, G | 1 |
Glicksberg, BS | 1 |
Houldsworth, J | 1 |
Cordon-Cardo, C | 1 |
Poon, WCK | 1 |
Brown, AT | 1 |
Direito, SOL | 1 |
Hodgson, DJM | 1 |
Le Nagard, L | 1 |
Lips, A | 1 |
MacPhee, CE | 1 |
Marenduzzo, D | 1 |
Royer, JR | 1 |
Silva, AF | 1 |
Thijssen, JHJ | 1 |
Titmuss, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load: A Randomized Controlled Trial[NCT05525832] | 50 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for guaifenesin and Infections, Coronavirus
Article | Year |
---|---|
A hypothesis on the role of the human immune system in covid-19.
Topics: Ageusia; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-1 | 2020 |
6 other studies available for guaifenesin and Infections, Coronavirus
Article | Year |
---|---|
Calpain-1: a Novel Antiviral Host Factor Identified in Porcine Small Intestinal Mucus.
Topics: Amino Acids; Animals; Antiviral Agents; Calcium; Calpain; Coronavirus Infections; Enteritis; Mucin-2 | 2022 |
Protective potential of expectorants against COVID-19.
Topics: Air Microbiology; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug T | 2020 |
Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Hot Temperature; Humans; Humidity; Mucus; Nasal C | 2020 |
SARS-CoV-2 viral load predicts COVID-19 mortality.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Male; Middle Aged; Mucus; N | 2020 |
Soft matter science and the COVID-19 pandemic.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Disinfection; Humans; Mucus; Nanoparticles; Pande | 2020 |
Protective potential of expectorants against COVID-19.
Topics: Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dioxolanes | 2020 |